Antipsychotics Do Not Provide a Clinically Meaningful Benefit Over the Short-Term: A Review of the Evidence
Mad in America
JUNE 21, 2025
No Trials in Medication-Naïve Patients When the first antipsychotic, chlorpromazine, was introduced into asylum medicine in 1954, there was no FDA requirement that the manufacturer of a drug had to conduct randomized clinical trials to prove its efficacy.
Let's personalize your content